Amarin Corp Plc (AMRN)

[KCSVEN]

Panel seems to question Primary vs secondary so concern label will not be as wide as Amarin wants, but still pretty wide but lost in all the stress going on. Vote is coming within hour, clear FDA is approving expanded label, just what the label will be is the question. If not too limiting should not be too harmful. However, it will be take as negative by street depending actual vote, probably drop back to where it was before docs came out? Then slowly back up when FDA approves. All my guess but Adcom's are stressful and always have a lot of negatives from panel.

I don't think people even understand the real difference in primary vs secondary and what it means for future sales but it sounds negative to not get the label you are asking for which is definitely possible here.

And the bets advice is to do what you did, not hang on every word. Wait for the vote and press release. Above was the negative slant, positive slant we get primary or close to it, also still very possible at the moment